Y Li, W Xu, Z Liao, B Yao, X Chen, Z Huang, G Hu, … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Optimal glycemic control was achieved within 6.3 ± 3.9 days by CSII in 126
patients. The remission rates (percentages maintaining near euglycemia) at the third, sixth,
twelfth, and twenty-fourth month were 72.6, 67.0, 47.1, and 42.3%, respectively. Patients ... Cited by 120 - Related articles - BL Direct - All 8 versions
EA Ryan, S Imes, C Wallace - Diabetes care, 2004 - Am Diabetes Assoc OBJECTIVE—Type 2 diabetes is associated with defects in insulin secretion and insulin
action. Hyperglycemia may aggravate these defects, a feature known as glucose toxicity. Previous
studies have shown that acute correction of hyperglycemia in subjects with long-standing ... Cited by 136 - Related articles - BL Direct - All 9 versions
H Ilkova, B Glaser, A Tunckale, N Bagriacik, E … - Diabetes Care, 1997 - Am Diabetes Assoc OBJECTIVE: Type 2 diabetes is a slowly progressive disease, in which the gradual deterioration
of glucose tolerance is associated with the progressive decrease in beta-cell function. Hyperglycemia
per se has deleterious effects on both beta-cell function and insulin action, which are ... Cited by 264 - Related articles - BL Direct - All 6 versions
S Park, SB Choi - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 23 - Related articles - BL Direct - All 3 versions
B Glaser, G Leibovich, R Nesher, S Hartling, C Binder, … - Acta Endocrinologica, 1988 - eje.org Abstract. In Type II, non-insulin-dependent diabetes, insulin secretion is often reduced to the
point where oral hypoglycaemic agents fail to control the plasma glucose level. We studied 12
patients (age 41–66 years; 4 lean, 8 obese) with Type II diabetes mellitus for 1–25 years ... Cited by 62 - Related articles - All 8 versions
- ►dminsulinpump.co.kr [PDF] J Weng, Y Li, W Xu, L Shi, Q Zhang, D Zhu, Y Hu, Z … - The Lancet, 2008 - Elsevier 382 patients, aged 25–70 years, were enrolled from nine centres in China between
September, 2004, and October, 2006. The patients, with fasting plasma glucose of 7·0–16·7
mmol/L, were randomly assigned to therapy with insulin (CSII or MDI) or oral ... Cited by 52 - Related articles - All 25 versions
- ►diabetesjournals.org M Alvarsson, G Sundkvist, I Lager, M Henricsson, K … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—ß-Cell function, glycemic control, and quality of life were
monitored over 2 years in 39 patients with islet cell antibody-negative type 2 diabetes diagnosed
0–2 years before inclusion in a Swedish multicenter randomized clinical trial. Patients ... Cited by 90 - Related articles - BL Direct - All 8 versions
H Chen, A Ren, S Hu, W Mo, X Xin, W Jia - Diabetes research and clinical …, 2007 - Elsevier This study was performed to investigate whether transient intensive insulin therapy with an insulin
pump (TIIT) can decrease serum tumor necrosis factor-α (TNF-α) and explore whether the decrease
of serum TNF-α has correlation with the improvement of islet β-Cell function and the ... Cited by 5 - Related articles - All 15 versions
